The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Unphosphorylated STAT1 prolongs the expression of interferon-induced immune regulatory genes
Open accessAbstract
In normal human cells treated with interferons (IFNs), the concentration of tyrosine-phosphorylated STAT1 (YP-STAT1), which drives the expression of a large number of genes, increases quickly but then decreases over a period of several hours. Because the STAT1 gene is activated by YP-STAT1, IFNs stimulate a large increase in the concentration of unphosphorylated STAT1 (U-STAT1) that persists for several days. To test the significance of high U-STAT1 expression, we increased its concentration exogenously in the absence of IFN treatment. In response, the expression of many immune regulatory genes (e.g., IFI27, IFI44, OAS, and BST2) was increased. In human fibroblasts or mammary epithelial cells treated with low concentrations of IFN-β or IFN-γ, the expression of the same genes increased after 6 h and continued to increase after 48 or 72 h, long after the concentration of YP-STAT1 had returned to basal levels. Consistent with its activity as a transcription factor, most U-STAT1 was present in the nuclei of these cells before IFN treatment, and the fraction in nuclei increased 48 h after treatment with IFN. We conclude that the nuclear U-STAT1 that accumulates in response to IFNs maintains or increases the expression of a subset of IFN-induced genes independently of YP-STAT1, and that many of the induced proteins are involved in immune regulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
Self-citationAntiviral Actions of Interferons
Samuel, C. E. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.778-809.2001 · Cited by 2,743
Distinctive gene expression patterns in human mammary epithelial cells and breast cancers
Perou, C. M., Jeffrey, S. S., van de Rijn, M., Rees, C. A., Eisen, M. B., Ross, D. T., Pergamenschikov, A., Williams, C. F., Zhu, S. X., Lee, J. C. F., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.16.9212 · Cited by 1,402
Yang, J., Liao, X., Agarwal, M. K., Barnes, L., Auron, P. E., & Stark, G. R. (2007) · Genes & Development · doi:10.1101/gad.1553707 · Cited by 611
Self-citationComplex modulation of cell type-specific signaling in response to type I interferons
van Boxel-Dezaire, A. H. H., Rani, M. R. S., & Stark, G. R. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.014 · Cited by 530
Self-citationDefective TNF-α-Induced Apoptosis in STAT1-Null Cells Due to Low Constitutive Levels of Caspases
Kumar, A., Commane, M., Flickinger, T. W., Horvath, C. M., & Stark, G. R. (1997) · Science · doi:10.1126/science.278.5343.1630 · Cited by 514
Self-citationBlasius, A. L., Giurisato, E., Cella, M., Schreiber, R. D., Shaw, A. S., & Colonna, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.5.3260 · Cited by 437
Bst‐2/HM1.24 Is a Raft‐Associated Apical Membrane Protein with an Unusual Topology
Kupzig, S., Korolchuk, V., Rollason, R., Sugden, A., Wilde, A., & Banting, G. (2003) · Traffic · doi:10.1034/j.1600-0854.2003.00129.x · Cited by 430
Novel roles of unphosphorylated STAT3 in oncogenesis and transcriptional regulation
Yang, J., Chatterjee-Kishore, M., Staugaitis, S. M., Nguyen, H., Schlessinger, K., Levy, D. E., & Stark, G. R. (2005) · Cancer Research · doi:10.1158/0008-5472.939.65.3 · Cited by 405 · cited 2×
“Our previous studies have already shown that unphosphorylated STAT3 is an active transcription factor (17, 18).”
BackgroundSelf-citationSTAT3 nuclear import is independent of tyrosine phosphorylation and mediated by importin-α3
Liu, L., McBride, K. M., & Reich, N. C. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501643102 · Cited by 348
Chatterjee-Kishore, M., Wright, K. L., Ting, J. P.-Y., & Stark, G. R. (2000) · The EMBO Journal · doi:10.1093/emboj/19.15.4111 · Cited by 346
Self-citationBiologic consequences of Stat1-independent IFN signaling
Gil, M. P., Bohn, E., O'Guin, A. K., Ramana, C. V., Levine, B., Stark, G. R., Virgin, H. W., & Schreiber, R. D. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111163898 · Cited by 344
Self-citationAlternative Activation of STAT1 and STAT3 in Response to Interferon-γ
Qing, Y., & Stark, G. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406413200 · Cited by 316
Self-citationActivation of the p38 Mitogen-activated Protein Kinase by Type I Interferons
Uddin, S., Majchrzak, B., Woodson, J., Arunkumar, P., Alsayed, Y., Pine, R., Young, P. R., Fish, E. N., & Platanias, L. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.30127 · Cited by 227
Widschwendter, A., Geymayer, S., Welte, T., Daxenbichler, G., Marth, C., & Doppler, W. (2002) · PubMed · Cited by 218
Lehtonen, A., Matikainen, S., & Julkunen, I. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.2.794 · Cited by 212
How cells respond to interferons revisited: From early history to current complexity
Stark, G. R. (2007) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2007.06.013 · Cited by 182
Self-citationConstitutive and IFN-γ-induced nuclear import of STAT1 proceed through independent pathways
Meyer, T., Begitt, A., Lödige, I., van Rossum, M., & Vinkemeier, U. (2002) · The EMBO Journal · doi:10.1093/emboj/21.3.344 · Cited by 181
Interferon, Mx, and viral countermeasures
Haller, O., Kochs, G., & Weber, F. (2007) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2007.06.001 · Cited by 177
Nucleocytoplasmic shuttling of STAT transcription factors
Meyer, T., & Vinkemeier, U. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04423.x · Cited by 153
Tassiulas, I. O., Hu, X., Ho, H. H., Kashyap, Y., Paik, P. K., Hu, Y., Lowell, C. A., & Ivashkiv, L. B. (2004) · Nature Immunology · doi:10.1038/ni1126 · Cited by 113
Cell Type-Specific and Tyrosine Phosphorylation-Independent Nuclear Presence of STAT1 and STAT3
Meyer, T., Gavénis, K., & Vinkemeier, U. (2002) · Experimental Cell Research · doi:10.1006/excr.2001.5405 · Cited by 95
Wang, K., Scheel‐Toellner, D., Wong, S. H., Craddock, R. M., Caamaño, J., Akbar, A. N., Salmon, M., & Lord, J. M. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.2.1035 · Cited by 95
Cui, X., Zhang, L., Luo, J., Rajasekaran, A., Hazra, S., Cacalano, N. A., & Dubinett, S. M. (2007) · Oncogene · doi:10.1038/sj.onc.1210222 · Cited by 63
Lesinski, G. B., Valentino, D., Hade, E. M., Jones, S., MAGRO, C. M. J., Chaudhury, A. R., Walker, M. J., & Carson, W. E. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-004-0649-y · Cited by 30
Klampfer, L., Huang, J., Kaler, P., Sasazuki, T., Shirasawa, S., & Augenlicht, L. H. (2006) · Oncogene · doi:10.1038/sj.onc.1210015 · Cited by 21
Cited by
Interferon-stimulated genes: A complex web of host defenses
Schneider, W. M., Chevillotte, M. D., & Rice, C. M. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120231 · Cited by 3,067
The JAK-STAT Pathway at Twenty
Stark, G. R., & Darnell, J. E. (2012) · Immunity · doi:10.1016/j.immuni.2012.03.013 · Cited by 1,517
Self-citationTumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
Benci, J. L., Xu, B., Qiu, Y., Wu, T. J., Dada, H., Twyman-Saint Victor, C., Cucolo, L., Lee, D. S. M., Pauken, K. E., Huang, A. C., et al. (2016) · Cell · doi:10.1016/j.cell.2016.11.022 · Cited by 1,216
“Interestingly, STAT1 has been shown to increase after persistent A random forest model for melanoma response/progression after anti-PD1 was developed using the number (Log10) of nsSNVs and the average mRNA expression of IFIT1 and MX1 (IFIT1/MX1) for a cohort of 27 patients.”
InfluentialMechanisms and consequences of Jak–STAT signaling in the immune system
Villarino, A. V., Kanno, Y., & O'Shea, J. J. (2017) · Nature Immunology · doi:10.1038/ni.3691 · Cited by 1,221
ISG15 in antiviral immunity and beyond
Perng, Y.-C., & Lenschow, D. J. (2018) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0020-5 · Cited by 855
Metadata
- Authors
- Cheon, H., & Stark, G. R.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2009-06-09
- Volume
- 106
- Issue
- 23
- Pages
- 9373-9378
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2091095196
- Cited by
- 305
- References
- 26
- FWCI
- 4.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.